Indefinite Delivery Contract 36C25222D0035
Award Date
4/1/22
Last Date to Order
9/30/23
Federal Agency
Veterans Integrated Service Network 12
Awardee
Cepheid
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Department of Veterans Affairs (VA) Veterans Integrated Service Network 2 (VISN 2) awarded an Indefinite Delivery Contract (IDC) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, for MRSA/PCR testing services at VA medical facilities in the VISN 2 region covering downstate New York. The single-award IDC, valued at up to $9,224,239.85, does not have a set-aside designation. Through a series of firm-fixed-price delivery orders issued against the IDC, Cepheid will provide...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 awarded a Blanket Purchase Agreement to Cepheid for real-time polymerase chain reaction molecular microbiology testing services. The testing is for the detection of Methicillin-resistant Staphylococcus aureus on a cost-per-test basis. Under subsequent calls against the BPA, Cepheid has provided these services from various places of performance including Sunnyvale, CA, Tucson, AZ, and San...
This federal Indefinite Delivery Contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 12 (VISN 12) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions. The contract has a ceiling value of $6,365,918.91 and an ultimate completion date of September 30, 2027. The contract is for the provision of Methicillin-resistant Staphylococcus aureus (MRSA) clinical and prevalence rate reduction (CPRR) testing and associated services...
The Department of Veterans Affairs (VA), Veterans Health Administration (VHA), Veterans Integrated Service Network 2 (VISN 2) awarded Cepheid, a for-profit manufacturer of molecular diagnostic solutions, a $518,924.36 firm fixed price Blanket Purchase Agreement (BPA) call contract to provide Cepheid's diagnostic testing products. The one-year contract, starting on September 11, 2023 and ending on September 10, 2024, will enable VISN 2 to continuously procure Cepheid's molecular diagnostic...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded Cepheid, located in Palo Alto, California, an indefinite delivery contract with a potential value of $6,000,000 to provide Cepheid GeneXpert and GeneXpress reagents. Three firm fixed price delivery orders were subsequently awarded against this contract from 2022 through 2027, with values ranging from $409,119.60 to $933,262.29. The reagents support Cepheid's molecular diagnostic...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 17 awarded Cepheid a single award indefinite delivery contract with a potential value of $1.4 million to provide COVID-19, influenza, and respiratory syncytial virus (RSV) plus SARS-CoV-2 diagnostic test kits. The contract has a last order date of April 30, 2028 and aims to procure test kits that are compatible with Cepheid instrumentation owned by the VA facility in Harlingen, Texas. Under this...
The Department of Veterans Affairs (VA) Veterans Integrated Service Network 19 has awarded a Blanket Purchase Agreement (BPA) to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, to provide CEPHEID REAGENTS, TEST KITS AND SUPPLIES. This single-award IDV contract has a ceiling value of $9,061,670.00 and a period of performance through September 30, 2025. The contract does not have a set-aside designation. Under this BPA, the VA has placed several task orders for Cepheid to...
The U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 8 awarded a single-award indefinite delivery contract to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, to procure reagents and test kits for the VA's GeneXpert diagnostic systems. The $3,783,614.55 delivery order contract has a performance period through March 31, 2025. Cepheid, as the original equipment manufacturer, will provide the VA with the necessary diagnostic consumables to support...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 (VA VHA VISN 8) awarded Cepheid, a subsidiary of Danaher Corporation, an indefinite delivery contract to provide reagents. Between April 2020 and November 2021, Cepheid received three firm fixed price delivery orders totaling $4,727,195 under this contract to supply reagents for use in VA VHA VISN 8's medical and laboratory services programs. The original solicitation indicated the...
Cepheid has been awarded an indefinite delivery contract by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 to provide molecular reagents in support of the Genexpert Infinity system. The single award contract has a potential value of $1,000,000 and a period of performance through September 30, 2025. Under the contract, Cepheid has received a $319,984 firm fixed price delivery order to supply molecular reagents to two VA medical facilities...
Name | Description | Awardee | Potential Value (Click to sort descending) | Award Date (Click to sort descending) | Completion Date (Click to sort descending) | Updated At (Click to sort descending) |
|---|---|---|---|---|---|---|
Delivery Order 36C25222D0035-36C25223N0064 | Cepheid | $318.6k | 10/1/22 | 4/17/23 | 7/18/23 | |
Delivery Order 36C25222D0035-36C25222N0343 | Cepheid | $292.0k | 4/1/22 | 9/30/22 | 3/8/23 | |
Delivery Order 36C25222D0035-36C25222N0374 | Cepheid | $72.1k | 4/18/22 | 9/30/22 | 3/9/23 | |
Delivery Order 36C25222D0035-36C25223N0299 | Cepheid | $457.4k | 4/1/23 | 9/30/23 | 1/31/24 |